AG00DE96

55028-72-3 | Cloprostenol sodium

Chemical structure of Cloprostenol sodium, CAS 55028-72-3
AG00DE96
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 55028-72-3
Catalog Number AG00DE96(AGN-PC-0SIK5V)
Chemical Name Cloprostenol sodium
EC Number 259-439-3
IUPAC Name sodium;(Z)-7-[(1R,2R,3R,5S)-2-[(E,3R)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate
InChI InChI=1S/C22H29ClO6.Na/c23-15-6-5-7-17(12-15)29-14-16(24)10-11-19-18(20(25)13-21(19)26)8-3-1-2-4-9-22(27)28;/h1,3,5-7,10-12,16,18-21,24-26H,2,4,8-9,13-14H2,(H,27,28);/q;+1/p-1/b3-1-,11-10+;/t16-,18-,19-,20+,21-;/m1./s1
InChI Key IFEJLMHZNQJGQU-KXXGZHCCSA-M
MDL Number MFCD11045985
Molecular Formula C22H28ClNaO6
Molecular Weight 446.8969
SMILES O=C([O-])CCC/C=CC[C@H]1[C@H](/C=C/[C@@H](O)COC2=CC=CC(Cl)=C2)[C@@H](O)C[C@H]1O.[Na+]
UNII 81129I41BJ
Synonyms
Cloprostenol, Cloprostenol Monosodium Salt, Cloprostenol Sodium, Estrumate, ICI 80,966, ICI-80,966, ICI80,966, Monosodium Salt, Cloprostenol, Oestrophan, Salt, Cloprostenol Monosodium, Sodium, Cloprostenol, Cloprostenol sodium, 55028-72-3, (+)-Cloprostenol sodium, Estrumate, (+/-)-Cloprostenol sodium salt, (+)-Cloprostenol, UNII-81129I41BJ, MFCD05863539, 81129I41BJ, Cloprostenol sodium salt, 62561-03-9, ICI 80996, Estroplan, 54276-21-0, NCGC00165774-02, C22H28ClNaO6, (+)-CLOPROSTENOL SODIUM SALT, Cloprostenol sodium [USAN:USP], Sodium (Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoate, EINECS 259-439-3, CLOPROSTENOL Na, D-Cloprostenol sodium salt, Cloprostenol sodium, (+)-, DSSTox_CID_26500, DSSTox_RID_81669, DSSTox_GSID_46500, SCHEMBL28242, MLS000028831, (5Z)-rel-Cloprostenol Sodium, BML2-G09, CHEMBL1520583, DTXSID1046500, HMS1361O21, HMS2235O09, HMS3268J10, EX-A1351, Tox21_112261, AKOS015967190, AKOS024457034, AC-6102, ICI 80,996, RP17749, NCGC00159550-01, (+-)-Sodium (Z)-7-((1R*,2R*,3R*,5S*)-2-((E)-(3R*)-4-(m-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptenoate, AC-25916, AN-10391, M202, SMR000058871, CAS-55028-72-3, X2625, (+/-)-16-(3-Chlorophenoxy)-9,11,15R-trihydroxy-17,18,19,20-tetranorprosta-5Z,13E-dien-1-oic acid sodium salt hydrate, J-524247, J-524252, UNII-886SAV9675 component IFEJLMHZNQJGQU-KXXGZHCCSA-M, (5Z)-rel-7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-5-heptenoic acid monosodium salt, (Z)-7-[2beta-[(1E,3R)-4-(3-Chlorophenoxy)-3-hydroxy-1-butenyl]-3alpha,5alpha-dihydroxycyclopentan-1alpha-yl]-5-heptenoic acid sodium salt, 5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl)-3,5-dihydroxycyclopentyl)-, sodium salt (1:1), (5Z)-, 5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, monosodium salt, (5Z)-rel-, 5-Heptenoic acid, 7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (1alpha(Z),2beta(1E,3R*),3alpha,5alpha)-, sodium salt, (+-)-, 5-Heptenoic acid, 7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, monosodium salt, (1alpha(Z),2beta(1E,3R*),3alpha,5alpha)-(+-)-, Sodium (1alpha(Z),2beta(1E,3R*),3alpha,5alpha)-(1)-7-(2-(4-(3-chlorophenoxy)-3-hydroxybut-1-enyl)-3,5-dihydroxycyclopentyl)hept-5-enoate, Sodium (E)-7-((1R,2R,3R,5S)-2-((R,E)-3-(3-Chlorophenoxy)-3-hydroxyprop-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoate, sodium (Z)-7-[(1R,2R,3R,5S)-2-[(E,3R)-4-(3-chlorophenoxy)-3-hydroxy-but-1-enyl]-3,5-dihydroxy-cyclopentyl]hept-5-enoate, Dalmazin, -Cloprostenol, D-Cloprostenol, R-Cloprostenol, Dalmaprost D, Cloprostenol, (+)-, UNII-52EJR3Y9IN, C22H29ClO6.Na, Cloprostenol sodium [USAN], UNII-886SAV9675, C22-H28-Cl-Na-O6, (+)-Cloprostenol (sodium salt), 886SAV9675, CID6852387, 2027S, 16-(m-Chlorophenoxy)-17,18,19,20-tetranorprostaglandin F2alpha, 5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl)-3,5-dihydroxycyclopentyl)-, (5Z)-, 5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (5Z)-, 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-, monosodium salt, (5Z)-rel-, 5-Heptenoic acid, 7-[2-[4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-, monosodium salt, [1.alpha.(Z),2.beta.(1E,3R*),3.alpha.,5.alpha.]-(.+-.)-, 5-Heptenoic acid, 7-[2-[4-(3-chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-, monosodium salt, [1.alpha.(Z),2.beta.(1E,3R*),3.alpha.,5.alpha.]-(.+.)-, Sodium [1alpha(Z),2beta(1E,3R*),3alpha,5alpha]-(+-)-7-[2-[4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited